Insights and News Curated for Life Science Experts by Life Science Experts....

INSIGHTS HUB

Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...

As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...

In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...

Indianapolis, IN, December 5, 2022 (PRNewswire) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as...

Cambridge, MA, December 6, 2022 (Reuters) -- Summit Therapeutics Inc (SMMT.O) said on Tuesday it would license China-based Akeso Inc's...

Oxford, UK, November 22, 2022 (Yahoo) -- Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell...

Seattle, WA, November 15, 2022 (Business Wire) -- Bonum Therapeutics, a biopharmaceutical company using allosteric regulation to create...

Elyria, OH, November 21, 2022 (Business Wire) -- Invacare Corporation (NYSE: IVC) announced today that its Board of Directors has named...

Cambridge, MA, November 21, 2022 (Business Wire) -- FogPharma®, a biopharmaceutical company pioneering a new class of precision...

Tel Aviv, Israel, November 21, 2022 (Business Wire) -- Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”) (NYSE and TASE:...

Waltham, MA, November 07, 2022 (Globe Newswire) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader...

Oxford, UK, November 07, 2022 (B3C newswire) -- OxSonics Therapeutics, a clinical-stage company focused on transforming cancer...

Tempe, AZ, October 31, 2022 (Business Wire) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company...

Raleigh, NC, November 1, 2022 (Business Wire) -- Focal Medical, Inc. (formerly Advanced Chemotherapy Technologies, Inc.), a privately...

Chicago, IL, November 3, 2022 (PRNewswire) -- Emalex Biosciences announced the closing of an upsized and oversubscribed $250 million...